Pvg Asset Management »

Cardiol Therapeutics Inc- foreign shares owned by Pvg Asset Management

Quarter-by-quarter ownership of Cardiol Therapeutics Inc- foreign (CRDL) shares owned by Pvg Asset Management from 13F filings

Historical chart of Pvg Asset Management investment in Cardiol Therapeutics Inc- foreign

Tip: Access up to 7 years of quarterly data

All positions including Cardiol Therapeutics Inc- foreign held by Pvg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardiol Therapeutics Inc- foreign by Pvg Asset Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $386k 284k 1.36
2025-03-31 $424k 437k 0.97
2024-12-31 $624k 487k 1.28

More positions owned by Pvg Asset Management

SPDR Barclays Capital 1-3 month Etf (BIL)
Vanguard Index S&P 500 Etf (VOO)
Journey Med Corp (DERM)
Anavex Life Sciences (AVXL)
S&p 500 Indx Etf (IVV)
Female Health (VERU)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Neos ETF Trust S&P 500 High Income Etf (SPYI)
Invesco ETF Tr S&P Equal Weighted Etf (RSP)
Grail (GRAL)
Fortress Biotech (FBIO)
ARK Innovation ETF Etf (ARKK)

View all positions for Pvg Asset Management

Top funds holding Cardiol Therapeutics Inc- foreign

Tejara Capital
AdvisorShares Investments
Marshall Wace
Citadel Advisors
Goldman Sachs Group
MMCAP International Inc. SPC
Pvg Asset Management
Two Sigma Investments
Virtu Financial
Sheets Smith Investment Management
Summit Financial
Jane Street
We Are One Seven
Knoll Capital Management
Morgan Stanley

View all funds holding Cardiol Therapeutics Inc- foreign